Novavax, Inc. (NVAX) Misses Q1 EPS by 1c
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
